ZA78676B - Semi-synthetic 4"-erythromycin a derivatives - Google Patents

Semi-synthetic 4"-erythromycin a derivatives

Info

Publication number
ZA78676B
ZA78676B ZA00780676A ZA78676A ZA78676B ZA 78676 B ZA78676 B ZA 78676B ZA 00780676 A ZA00780676 A ZA 00780676A ZA 78676 A ZA78676 A ZA 78676A ZA 78676 B ZA78676 B ZA 78676B
Authority
ZA
South Africa
Prior art keywords
erythromycin
derivatives
semi
synthetic
Prior art date
Application number
ZA00780676A
Other languages
English (en)
Inventor
F Sciavolino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA78676B publication Critical patent/ZA78676B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA00780676A 1977-02-04 1978-02-03 Semi-synthetic 4"-erythromycin a derivatives ZA78676B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76548077A 1977-02-04 1977-02-04

Publications (1)

Publication Number Publication Date
ZA78676B true ZA78676B (en) 1978-12-27

Family

ID=25073668

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00780676A ZA78676B (en) 1977-02-04 1978-02-03 Semi-synthetic 4"-erythromycin a derivatives

Country Status (10)

Country Link
US (1) US4150220A (fr)
JP (3) JPS5853000B2 (fr)
AT (1) AT359643B (fr)
BE (1) BE863621A (fr)
CS (2) CS221803B2 (fr)
DD (1) DD143779A5 (fr)
HU (1) HU184999B (fr)
PL (1) PL115793B1 (fr)
SU (3) SU837326A3 (fr)
ZA (1) ZA78676B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283527A (en) * 1980-04-01 1981-08-11 Pfizer Inc. Erythromycylamine 11,12-carbonate and derivatives thereof
US4413119A (en) * 1982-03-01 1983-11-01 Pfizer Inc. Semi-synthetic macrolides
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents
US4363803A (en) * 1982-03-01 1982-12-14 Pfizer Inc. 3",4"-Oxyallylene erythromycin and oleandomycin, composition and method of use
US4382086A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-erythromycin A
DK149776C (da) * 1984-01-06 1987-04-21 Orion Yhtymae Oy Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US4847242A (en) 1985-03-12 1989-07-11 Beecham Group P.L.C. 11-ether derivatives of erythromycins
US5175150A (en) * 1985-08-31 1992-12-29 Kitasato, Kenkyusho Erythromycin derivative
US4672056A (en) * 1985-11-12 1987-06-09 Abbott Laboratories Erythromycin A derivatives and method of use
FR2639945B1 (fr) * 1988-12-07 1994-03-25 Oreal Ethers et/ou esters lipophiles de d-desosamine, leur procede de preparation et leur utilisation en tant qu'agents antibacteriens et antifongiques
US5808017A (en) * 1996-04-10 1998-09-15 Abbott Laboratories Process for preparing erythromycin A oxime
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives
US3842069A (en) * 1973-06-21 1974-10-15 Abbott Lab 4"-deoxy-4"-oxoerythromycin b derivatives

Also Published As

Publication number Publication date
CS221803B2 (en) 1983-04-29
ATA75378A (de) 1980-04-15
SU1172451A3 (ru) 1985-08-07
DD143779A5 (de) 1980-09-10
CS221802B2 (en) 1983-04-29
JPS57154199A (en) 1982-09-22
JPS5827800B2 (ja) 1983-06-11
SU886749A3 (ru) 1981-11-30
JPS57158799A (en) 1982-09-30
BE863621A (fr) 1978-08-03
PL115793B1 (en) 1981-04-30
JPS597718B2 (ja) 1984-02-20
AT359643B (de) 1980-11-25
JPS5853000B2 (ja) 1983-11-26
JPS57154198A (en) 1982-09-22
HU184999B (en) 1984-11-28
SU837326A3 (ru) 1981-06-07
US4150220A (en) 1979-04-17

Similar Documents

Publication Publication Date Title
NZ187453A (en) Benzsubstituted-1-substitutedpiperid-1'-ylphthalazines
CS550778A2 (en) Usporadani pohonu pracovniho stolu obrabeciho stroje s podavacim a snimacim zarizenim upinacich desek
AU4113878A (en) 1-alkanoyl-proline derivatives
JPS5484554A (en) 11nn4*66diioo*aminoglycocyl**1*33diamino sicritol derivatives
ZA78676B (en) Semi-synthetic 4"-erythromycin a derivatives
GB1557019A (en) Metalsulphonamido-benzamide derivatives
GB1557552A (en) 1 oxadethiacepham compounds
MTP837B (en) Derivatives 2 finino-imidazolidire
AU3888578A (en) 4-hydroxy-2-benzimidazolinone derivatives
ZA78646B (en) Semi-synthetic 4"-amino-oleandomycin derivatives
PH14421A (en) Semi-synthetic 4"erythromycin a derivatives
JPS5419978A (en) 1*2*44oxadiazol derivative
JPS5463100A (en) 55substitutedd10*111dihydroo5hhdibenzoo*a*d** cycloheptenee5*100imine
JPS5463095A (en) Semiisynthesized 4**ureiddoleandomycin derivative
GB2010805B (en) 6'-epi-fortimicin a and b derivatives
AU3313978A (en) Everninomicin derivatives
NZ187675A (en) 1-imidazolidin-2'-ylideneaminoindolines
GB2000128B (en) 15-substituted-omega-pentanorprostaglandin derivatives
JPS5432474A (en) 33*1hhtetrazolee55yl* chromones
GB2000769A (en) 4 - homoisotwistane derivatives
EG13371A (en) Semi-synthetic 4"-sulfonyl amino-oleandomycin derivatives
AU4129978A (en) Eburnamenine derivatives
JPS5484574A (en) Andiotensin 2 derivative
IL61606A (en) Semi-synthetic 4"-aminooleandomycin derivatives
GB1518784A (en) Preparation of a 4,6-diamino-5-arylazo-pyrimidine